The objective of the project is to develop, evaluate and apply informative statistical methods to the task of identifying novel genes/pathways involved in breast cancer recurrence. A model for time to cancer recurrence using clinical, pathological, and molecular measures in the setting of high-dimensional genome-wide genetic scans will be developed that allows for a proportion of the patients to be long-term survivors.